Challenges and Countermeasures of Chinese Medicine Enterprises under the Background of National Implementation of Collective Procurement of Proprietary Chinese Medicines

DING Tiantian, TAN Zaixiang, QIAN Aibing

PDF(2362 KB)
主办：上海医药工业研究院
　　　中国药学会
　　　中国化学制药工业协会
ISSN 1001-8255   CN 31-1243/R   ZYGZEA
Chinese Journal of Pharmaceuticals
PDF(2362 KB)
Chinese Journal of Pharmaceuticals ›› 2023, Vol. 54 ›› Issue (05) : 800-804. DOI: 10.16522/j.cnki.cjph.2023.05.023
Pharmaceutical Management & Information

Challenges and Countermeasures of Chinese Medicine Enterprises under the Background of National Implementation of Collective Procurement of Proprietary Chinese Medicines

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 54(05): 800-804 https://doi.org/10.16522/j.cnki.cjph.2023.05.023

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(2362 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉